Literature DB >> 10426842

Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

A Uemura1, S Morimoto, S Hiramitsu, Y Kato, T Ito, H Hishida.   

Abstract

BACKGROUND: An early diagnosis of cardiac sarcoidosis is important, particularly when considering the need for administering corticosteroid therapy. However, no reports are available on the success rate of diagnosis on the basis of biopsy findings in patients with cardiac sarcoidosis. This study investigated the diagnostic success rate of histologic evaluation of endomyocardial biopsy specimens in patients with this disease. METHODS AND
RESULTS: Right ventricular endomyocardial biopsy was performed in 26 patients in whom cardiac sarcoidosis was strongly suspected according to the Diagnostic Criteria of Sarcoidosis, plus abnormalities on the electrocardiogram, cardiac radionuclide images, or in left ventricular wall motion. A mean of 4.0 sites were sampled per patient. In each case we determined whether a definitive diagnosis of cardiac sarcoidosis could be made histologically. Noncaseating granulomas were found in only 5 (19.2%) of the 26 cases, thus permitting a histologic diagnosis of cardiac sarcoidosis. A histologic diagnosis was made in 4 (36.4%) of 11 patients who exhibited a dilated cardiomyopathy-like clinical picture, in contrast to only 1 (6.7%) of 15 patients in whom conduction disturbances were the major clinical feature and whose left ventricular ejection fraction was within normal limits.
CONCLUSIONS: The diagnostic rate achieved with biopsy in cardiac sarcoidosis is low; the patients with sarcoidosis and evidence of significant cardiac involvement should be treated for cardiac sarcoidosis despite negative myocardial biopsies for this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426842     DOI: 10.1016/s0002-8703(99)70115-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  92 in total

1.  A 28 year old woman with ventricular tachycardia and an abnormal chest radiograph.

Authors:  M Heath; H Deubner; E J Stern; J E Cooke; E A Gill
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  Three-dimensional electroanatomic voltage mapping to guide biopsy sampling in unexplained cardiomyopathies: a proof-of-principle case series.

Authors:  Dirk G Dechering; Simon Kochhäuser; Stephan Zellerhoff; Gerrit Frommeyer; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2016-02       Impact factor: 5.460

3.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

Review 4.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 5.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

6.  Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation.

Authors:  E Hyodo; T Hozumi; Y Takemoto; H Watanabe; T Muro; H Yamagishi; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Untreated cardiac sarcoidosis with active inflammation: Severe left ventricular dysfunction and ventricular wall thinning in three years.

Authors:  Ryota Kakizaki; Toshimi Koitabashi; Yoshiyasu Minami; Takeru Nabeta; Toyoji Kaida; Shunsuke Ishii; Emi Maekawa; Takayuki Inomata; Junya Ako
Journal:  J Cardiol Cases       Date:  2017-08-05

8.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

9.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

10.  Assessment of cardiac involvement in sarcoidosis by echocardiography.

Authors:  Marta Focardi; Andrea Picchi; Nikolas Nikiforakis; Elena Bargagli; Antonella Fossi; Claudia Maggiorelli; Sergio Mondillo; Paola Rottoli
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.